【结 构 式】 |
【分子编号】32901 【品名】lithium 1-phenyl-4,5-dihydro-1H-pyrrol-2-olate 【CA登记号】 |
【 分 子 式 】C10H10LiNO 【 分 子 量 】167.13654 【元素组成】C 71.86% H 6.03% Li 4.15% N 8.38% O 9.57% |
合成路线1
该中间体在本合成路线中的序号:(III)The formation of the free carboxyl group derivative (IV), as shown in Scheme 22578901b, was suggested to occur through formation of the diasteromeric lactone intermediates (VIIIa, b). Although there is no evidence to support the following mechanism, it has been hypothesized that only the syn-lactone can eliminate in the presence of one equivalent of LiOEt to give the free carboxyl derivative which is then transformed into the final compound (IV). Conversely, as far as the anti-lactone derivative is concerned, it seems that, for steric reasons, this intermediate is unable to reach the necessary antiperiplanar conformation to evolve towards the Z-elimination product. In the latter case, LiOEt, acting this time as a nucleophile, could afford lithium aldolate (VII). The final retroaldolic reaction could regenerate the starting materials (II) and (III), repeating the aldol-elimination-lactonization process.
【1】 Di Fabio, R.; et al.; Substituted indole-2-carboxylates as in vivo potent antagonists acting at the strychnine-insensitive glycine binding site. J Med Chem 1997, 40, 6, 841-850. |
【2】 Di Fabio, R.; Corsi, M.; Ugolini, A.R.; Gaviraghi, G.; Giacobbe, S.; Gastaldi, P.; Pentassuglia, G.; Quartaroli, M.; Conti, N.; Donati, D.; Trist, D.G.; Ratti, E.; GV196771. Drugs Fut 2000, 25, 2, 137. |
【3】 Giacobbe, S.A.; Baraldi, D.; Di Fabio, R.; Unusual synthesis of new glycine antagonists via sequential aldol condensation-lactonization-elimination reaction. Bioorg Med Chem Lett 1998, 8, 13, 1689-92. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VIIa) | 32902 | ethyl 4,6-dichloro-3-[(S)-hydroxy[(3R)-2-oxo-1-phenylpyrrolidinyl]methyl]-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-indole-2-carboxylate | C28H34Cl2N2O5Si | 详情 | 详情 | |
(VIIb) | 32903 | ethyl 4,6-dichloro-3-[(S)-hydroxy[(3S)-2-oxo-1-phenylpyrrolidinyl]methyl]-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-indole-2-carboxylate | C28H34Cl2N2O5Si | 详情 | 详情 | |
(VIIIa) | 32904 | (1R)-6,8-dichloro-1-[(3S)-2-oxo-1-phenylpyrrolidinyl]-4-[[2-(trimethylsilyl)ethoxy]methyl]-1,4-dihydro-3H-furo[3,4-b]indol-3-one | C26H28Cl2N2O4Si | 详情 | 详情 | |
(VIIIb) | 32905 | (1R)-6,8-dichloro-1-[(3R)-2-oxo-1-phenylpyrrolidinyl]-4-[[2-(trimethylsilyl)ethoxy]methyl]-1,4-dihydro-3H-furo[3,4-b]indol-3-one | C26H28Cl2N2O4Si | 详情 | 详情 | |
(II) | 32870 | ethyl 4,6-dichloro-3-formyl-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-indole-2-carboxylate | C18H23Cl2NO4Si | 详情 | 详情 | |
(III) | 32901 | lithium 1-phenyl-4,5-dihydro-1H-pyrrol-2-olate | C10H10LiNO | 详情 | 详情 | |
(IV) | 32872 | 4,6-dichloro-3-[(2-oxo-1-phenyl-3-pyrrolidinylidene)methyl]-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-indole-2-carboxylic acid | C26H28Cl2N2O4Si | 详情 | 详情 |